Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> LUNG CANCER Latest News

APR 01, 2014 - MedPage Today

A Must Read - Share

Mixed Results in NSCLC, SCLC Trials (CME/CE)

(MedPage Today) -- Two-thirds of patients with recurrent, mutated non-small cell lung cancer responded to an investigational agent that selectively targets mutant cells and spares normal ones, results of a preliminary trial showed.

Tags: Mixed Results in NSCLC, SCLC Trials (CME/CE),  Lung Cancer Latest News